Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02166905
Title DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications

ovarian carcinoma

fallopian tube carcinoma

peritoneal carcinoma

Therapies

Poly ICLC

Rasdegafusp alfa

Epacadostat

Age Groups: adult
Covered Countries USA


No variant requirements are available.